Literature DB >> 17236804

Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions.

Michelle C Callegan1, Michael S Gilmore, Meredith Gregory, Raniyah T Ramadan, Brandt J Wiskur, Andrea L Moyer, Jonathan J Hunt, Billy D Novosad.   

Abstract

Endophthalmitis is an infection of the posterior segment of the eye that frequently results in loss of vision. This devastating result occurs despite prompt and often aggressive therapeutic and surgical intervention. Over the past decade, research has centered on determining the bacterial and host factors involved in this potentially blinding disease. The initial focus on the bacterial factors responsible for intraocular virulence has recently expanded into analysis the inflammatory response to infection, including the molecular and cellular interactions between the pathogen and host. This review discusses the epidemiology and therapeutic challenges posed by endophthalmitis, as well as recent findings from the analysis of interactions between the host and pathogen. Based on these findings, a model for the pathogenesis of endophthalmitis is presented. A more comprehensive understanding of the molecular and cellular interactions taking place between pathogen and host during endophthalmitis will expose possible therapeutic targets designed to arrest the infection and prevent vision loss.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17236804      PMCID: PMC1941835          DOI: 10.1016/j.preteyeres.2006.12.001

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  115 in total

Review 1.  Immunopathogenic mechanisms in intraocular inflammation.

Authors:  J V Forrester; P G McMenamin
Journal:  Chem Immunol       Date:  1999

Review 2.  Mechanisms of intraocular inflammation.

Authors:  M T Magone; S M Whitcup
Journal:  Chem Immunol       Date:  1999

3.  Adhesion molecule expression in a rat model of Staphylococcus aureus endophthalmitis.

Authors:  M J Giese; D C Shum; S A Rayner; B J Mondino; J A Berliner
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-01       Impact factor: 4.799

4.  The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001.

Authors:  Emily S West; Ashley Behrens; Peter J McDonnell; James M Tielsch; Oliver D Schein
Journal:  Ophthalmology       Date:  2005-08       Impact factor: 12.079

5.  Retinal detachment in the endophthalmitis vitrectomy study.

Authors:  B M Doft; S F Kelsey; S R Wisniewski
Journal:  Arch Ophthalmol       Date:  2000-12

6.  Prognostic factors in ocular injuries caused by intraocular or retrobulbar foreign bodies.

Authors:  J B Jonas; H L Knorr; W M Budde
Journal:  Ophthalmology       Date:  2000-05       Impact factor: 12.079

Review 7.  Endogenous bacterial endophthalmitis: an east Asian experience and a reappraisal of a severe ocular affliction.

Authors:  J S Wong; T K Chan; H M Lee; S P Chee
Journal:  Ophthalmology       Date:  2000-08       Impact factor: 12.079

8.  Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.

Authors:  J H Sohn; H J Kaplan; H J Suk; P S Bora; N S Bora
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

9.  Effects of intravitreal corticosteroids in the treatment of Bacillus cereus endophthalmitis.

Authors:  S M Liu; T Way; M Rodrigues; S M Steidl
Journal:  Arch Ophthalmol       Date:  2000-06

10.  Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes.

Authors:  C L Lobo; R C Bernardes; J G Cunha-Vaz
Journal:  Arch Ophthalmol       Date:  2000-10
View more
  76 in total

1.  Effect of emergence of fluoroquinolone resistance on intrinsic expression of P-glycoprotein phenotype in corneal epithelial cells.

Authors:  Megha Barot; Mitan R Gokulgandhi; Megan Haghnegahdar; Pranjali Dalvi; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2011-08-10       Impact factor: 2.671

2.  Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis.

Authors:  Andrea L Moyer; Raniyah T Ramadan; Billy D Novosad; Roger Astley; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-05       Impact factor: 4.799

3.  Endogenous aspergillus endophthalmitis after kidney transplantation.

Authors:  Huan-Huan Cheng; Yong Ding; Min Wu; Cui-Cui Tang; Ri-Jia Zhang; Xiao-Feng Lin; Jin-Tang Xu
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

4.  Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitis.

Authors:  Michelle C Callegan; Scott Guess; Nanette R Wheatley; Dustin C Woods; Gabe Griffin; Brandt J Wiskur; Robert Leonard
Journal:  Retina       Date:  2011-09       Impact factor: 4.256

Review 5.  Targets of immunomodulation in bacterial endophthalmitis.

Authors:  Frederick C Miller; Phillip S Coburn; Mursalin Md Huzzatul; Austin L LaGrow; Erin Livingston; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2019-05-28       Impact factor: 21.198

6.  Antiinflammatory effect of low-level laser therapy on Staphylococcus epidermidis endophthalmitis in rabbits.

Authors:  Wen-jiang Ma; Xiao-rong Li; Ying-xin Li; Zhi-xiao Xue; Hui-juan Yin; Hui Ma
Journal:  Lasers Med Sci       Date:  2011-09-27       Impact factor: 3.161

Review 7.  Muller glia in retinal innate immunity: a perspective on their roles in endophthalmitis.

Authors:  Ashok Kumar; Rajeev K Pandey; Lindsay J Miller; Pawan K Singh; Mamta Kanwar
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

8.  Toward improving therapeutic regimens for Bacillus endophthalmitis.

Authors:  Brandt J Wiskur; Michael L Robinson; Allison J Farrand; Billy D Novosad; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

9.  A role for tumor necrosis factor-alpha in experimental Bacillus cereus endophthalmitis pathogenesis.

Authors:  Raniyah T Ramadan; Andrea L Moyer; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-27       Impact factor: 4.799

10.  Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics.

Authors:  Joseph S Bertino
Journal:  Clin Ophthalmol       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.